Apopark SA
1.5 FTEApopark reported total assets of 210,821 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026), with 1.5 full-time equivalent.
The score of Apopark shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets -4 % Headcount (avg FTE) +50 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apopark's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 35,302 € | ||||
| Equity | 157,479 € | ||||
| Cash | 53,551 € | ||||
| EBITDA | 63,320 € | ||||
| Total assets | 210,821 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Apopark's financial analysis
- Solvency74.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apopark
Apopark's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0411.894.860
- VAT number
- BE0411894860
- Peppol
- Registered · 0208:0411894860 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Jan 1972
- Registered office
- 3000 Leuven
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apopark (SA) has been based in Leuven since 1972, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 35,302 € and equity of 157,479 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 74.7%, above the median of its sector (44.2%).
Companies similar to Apopark
Companies in the same business, of comparable size and area, outside its group.
- LA Pharmacie DU Parc Retail sale of pharmaceutical products Grez-Doiceau · balance sheet 210,632 €
- Amboplus Retail sale of pharmaceutical products Knokke-Heist · balance sheet 212,418 €
- Apotheek VAN Hemelrijk Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 208,504 €
- Castoro Retail sale of pharmaceutical products Pajottegem · balance sheet 213,183 €
- LE Lumeçon Retail sale of pharmaceutical products Brussels · balance sheet 213,394 €
- MDB Pharma Retail sale of pharmaceutical products Ghent · balance sheet 214,811 €
- Pharmasolutions Retail sale of pharmaceutical products Linkebeek · balance sheet 215,436 €
- Phidelta Pharma Retail sale of pharmaceutical products Liège · balance sheet 216,336 €
Frequently asked questions about Apopark
What is the revenue of Apopark?
Apopark files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apopark?
In Belgium, the VAT number is the company number prefixed with BE: BE0411894860 for Apopark, if the company is VAT-registered. Its company number (CBE) is 0411.894.860.
Where is the registered office of Apopark?
According to the CBE register, the registered office of Apopark is in 3000 Leuven.
What is the equity of Apopark?
At the close of the 2025 financial year, the equity of Apopark amounts to 157,479 €, a solvency of 74.7% of total assets.
How many people work at Apopark?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apopark?
The register lists 2 active mandates at Apopark. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apopark
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →